The aim of this study was to assess the seroprevalence, viremia, genotype distribution, and demographic history of hepatitis C virus (HCV) in the Republic of the Congo. Testing was carried out on sera samples collected in 2005 from 807 Bantus belonging to the Kongo, Teke, and Ngala subgroups and 80 Pygmies. Positive HCV serology was found in 50 (5.6%) individuals including31 (60%) who were viremic. Seroprevalence increased with age with a cutoff at 50 years:2.8% <50 versus 12% >50. Twenty-one strains belonged to four described subtypes, that is, 4c in eight cases, 4h in two, 4k in three, and 4r in eight. Ten strains could not be assigned to any known subtype and may represent six new variants, that is, subtype 4 in five cases and subtype 2 ...
Understanding the origin and nature of hepatitis C virus (HCV) genetic diversity is critical for imp...
International audienceTo determine the prevalence of hepatitis C virus (HCV) infection and genotype ...
Hepatitis C (HCV) molecular epidemiology is documented poorly in central African countries. In respo...
The aim of this study was to assess the seroprevalence, viremia, genotype distribution, and demograp...
The prevalence and genetic diversity of hepatitis C virus (HCV) and human pegivirus (HPgV) in many r...
Background: The epidemiological and molecular characteristics of hepatitis C virus (HCV) infection i...
BACKGROUND: The epidemiological and molecular characteristics of hepatitis C virus (HCV) infection i...
HCV genotype 4 is prevalent in many African countries, yet little is known about the genotype׳s epid...
AbstractHCV genotype 4 is prevalent in many African countries, yet little is known about the genotyp...
International audienceHepatitis C virus (HCV) infection in Cameroon is characterized by widespread s...
HCV genotype 4 is prevalent in many African countries, yet little is known about the genotype׳s epid...
Hepatitis C (HCV) molecular epidemiology is documented poorly in central African countries. In respo...
Hepatitis C virus (HCV) causes severe illness in millions of people worldwide, but the epidemic stra...
The global plan to eradicate hepatitis C virus (HCV) led by the World Health Organization outlines t...
Understanding the origin and nature of hepatitis C virus (HCV) genetic diversity is critical for imp...
Understanding the origin and nature of hepatitis C virus (HCV) genetic diversity is critical for imp...
International audienceTo determine the prevalence of hepatitis C virus (HCV) infection and genotype ...
Hepatitis C (HCV) molecular epidemiology is documented poorly in central African countries. In respo...
The aim of this study was to assess the seroprevalence, viremia, genotype distribution, and demograp...
The prevalence and genetic diversity of hepatitis C virus (HCV) and human pegivirus (HPgV) in many r...
Background: The epidemiological and molecular characteristics of hepatitis C virus (HCV) infection i...
BACKGROUND: The epidemiological and molecular characteristics of hepatitis C virus (HCV) infection i...
HCV genotype 4 is prevalent in many African countries, yet little is known about the genotype׳s epid...
AbstractHCV genotype 4 is prevalent in many African countries, yet little is known about the genotyp...
International audienceHepatitis C virus (HCV) infection in Cameroon is characterized by widespread s...
HCV genotype 4 is prevalent in many African countries, yet little is known about the genotype׳s epid...
Hepatitis C (HCV) molecular epidemiology is documented poorly in central African countries. In respo...
Hepatitis C virus (HCV) causes severe illness in millions of people worldwide, but the epidemic stra...
The global plan to eradicate hepatitis C virus (HCV) led by the World Health Organization outlines t...
Understanding the origin and nature of hepatitis C virus (HCV) genetic diversity is critical for imp...
Understanding the origin and nature of hepatitis C virus (HCV) genetic diversity is critical for imp...
International audienceTo determine the prevalence of hepatitis C virus (HCV) infection and genotype ...
Hepatitis C (HCV) molecular epidemiology is documented poorly in central African countries. In respo...